The second part of our investigation shows how Moderna carefully monitored and attacked voices questioning mandates, industry profiteering, and the efficacy and safety of childhood vaccinations.
Exclusive Moderna documents show how the vaccine maker is monitoring online discourse and partnering with an NGO with a history of censoring social media.
By Eve Ottenberg, CounterPunch August 25, 2023 During the pandemic, poor people did not have to renew their Medicaid annually. Now that covid is supposedly over, that has changed. Unwinding, Read More…
By Jake Johnson September 15, 2021 While combing through a leaked contract published earlier this year by an Italian broadcaster, the U.S.-based consumer advocacy group Public Citizen identified a component of Pfizer-BioNTech’s secretive Read More…
Instead, those drugs are being sold for thousands of dollars each, proving once again that the private, for-profit pharmaceutical industry is ill-equipped to handle a global public health crisis like COVID-19.
What is the next step in the evolution of the COV-19 Crisis?
A coronavirus vaccine program was announced in Davos at the World Economic Forum (January 21-24) barely 2 weeks after the cornonavirus was identified by the Chinese authorities on January 7.
“It is insane and unacceptable,” said Bernie Sanders. “We will not tolerate profiteering. Any treatment or vaccine must be made free for all.”
On Thursday, January 12, 2017, 13 Democrats split from the majority of the party to join the Republican majority in the Senate in voting against a proposal submitted by Senator Bernie Sanders (I-VT) and co-sponsored with Senator Amy Klobuchar (D-MN), that would allow U.S. citizens to legally import prescription drugs from Canada at lower prices. The amendment was voted down with the final vote count at 52 to 46, with one senator each from both parties not voting. Meanwhile, 13 Republicans surprisingly defected from the party majority to cross the aisle in favor of it.
© Copyright, copyleft 2016 - 2024 SNEWS PRESS. All rights reversed.
Privacy Policy
